Purchases and Sales Made in Q1 2023 in Monopar Therapeutics (MNPR)
This table provides information about the institutional ownership of Monopar Therapeutics (MNPR) during Q1 2023. The information is specifically focused on institutions that hold shares of Monopar Therapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 12, 2023
Q1 2023
|
Kestra Private Wealth Services, LLC
|
BUY
|
- |
23.5KNew |
$32.6K - $87.5K
|
23.5K
$1.14M
|
|
|
May 15, 2023
Q1 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
5KNew |
$6.95K - $18.7K
|
5K
$243K
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
BUY
|
- |
3.23K+ 102.54% |
$4.5K - $12.1K
|
6.39K
$310K
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
2.41KNew |
$3.36K - $9K
|
2.41K
$117K
|
|
|
May 15, 2023
Q1 2023
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
970+ 2.69% |
$1.35K - $3.62K
|
37.1K
$1.8M
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 09, 2023
Q1 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.12K- 74.81% |
$2.94K - $7.9K
|
713
$34.6K
|